Friday, 29th March
Register
Log in
Password recovery
Menu
COVID-19
Alzheimer’s & Dementia
Cancer
Diabetes
Heart & Lung
Infection
Men’s
Women’s
Mental
Muscular
Surgery
Innovation
Sexual Health
Paediatrics
Lifestyle
NHS
Medico-Legal
Neurodiversity
Reproductive Health
Nutrition
Aesthetic
CPD
Global Reach
Drugs
[esi adrotate group="1" cache="private" ttl="0"]
Andrew Gallagher
About
Latest Posts
Andrew Gallagher
Andrew Gallagher is chief operating officer at Phynova, a British life science company that develops and sells medically licensed drugs, functional ingredients and cosmeceuticals derived from active compounds found in plants.
Latest posts by Andrew Gallagher
(
see all
)
Licensing traditional Chinese medicines
- 15th September 2016
Licensing traditional Chinese medicines